Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Molecular Characterization of the Human Stomach Microbiota in Gastric Cancer Patients

作者:Guoqin Yu, Javier Torres, Nan Hu, Rafael Medrano‐Guzmán, Roberto Herrera‐Goepfert, Michael S. Humphrys, Lemin Wang, Chaoyu Wang, Ti Ding, Jacques Ravel, Philip R. Taylor, Christian C. Abnet, Alisa M. Goldstein · 发表于:Frontiers in Cellular and Infection Microbiology · 年份:2017 · DOI:10.3389/fcimb.2017.00302 · 被引用次数:155 · 研究领域:Helicobacter pylori-related gastroenterology studies、Gut microbiota and health、Gastric Cancer Management and Outcomes

Helicobacter pylori (Hp) is the primary cause of gastric cancer but we know little of its relative abundance and other microbes in the stomach, especially at the time of gastric cancer diagnosis. Here we characterized the taxonomic and derived functional profiles of gastric microbiota in two different sets of gastric cancer patients, and compared them with microbial profiles in other body sites. Paired nonmalignant and tumor tissues were sampled from 160 gastric cancer patients with 80 from China and 80 from Mexico. The 16S rRNA gene V3-V4 region was sequenced using MiSeq platform for taxonomic profiles. PICRUSt was used to predict functional profiles. Human Microbiome Project was used for comparison. We showed that Hp is the most abundant member of gastric microbiota in both Chinese and Mexican samples (51% and 24% respectively), followed by oral-associated bacteria. Taxonomic (phylum-level) profiles of stomach microbiota resembled oral microbiota, especially when the Helicobacter reads were removed. The functional profiles of stomach microbiota, however, were distinct from those found in other body sites and had higher inter-subject dissimilarity. Gastric microbiota composition did not differ by Hp colonization status or stomach anatomic sites, but did differ between paired non-malignant and tumor tissues in either Chinese or Mexican samples. Our study showed that Hp is the dominant member of the non-malignant gastric tissue microbiota in many gastric cancer patients. Our r...